4basebio PLC, a gene therapy company, is aiming to revolutionize the field’s technology and solutions. Their primary focus has been to create synthetic DNA, which offers numerous benefits such as higher safety, efficacy, and cost-saving in comparison to plasmid DNA. The company's near-term goal is to develop Good Manufacturing Practice (GMP) grade synthetic DNA, a crucial milestone in the commercialization of their core technology.